US00182C1036
© Globe Newswire
06.01.2026
ANIP
LISTED
NASDAQ
ANI Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
PRINCETON, N.J., Jan. 06, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 3:00 p.m. PT / 6:00 p.m. ET....
Themefolio
Profiler
Peergroup
© Globe Newswire
11.11.2025
ANIP
LISTED
NASDAQ
ANI Pharmaceuticals to Present at the Jefferies Global Healthcare Conference – London
News Preview
PRINCETON, N.J., Nov. 11, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference – London on Tuesday, November 18, at 3:00 p.m. GMT/10:00 a.m. ET....
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ANIP
LISTED
NASDAQ
ANI Pharmaceuticals Reports Record Third Quarter 2025 Financial Results and Raises 2025 Guidance
News Preview
PRINCETON, N.J., Nov. 07, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced financial results and business highlights for the third quarter ended September 30, 2025....
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Globe Newswire
24.10.2025
ANIP
LISTED
NASDAQ
ANI Pharmaceuticals to Discuss Third Quarter 2025 Financial Results on November 7, 2025, at 8:30 a.m. ET
News Preview
PRINCETON, N.J., Oct. 24, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that the Company will release its third quarter 2025 financial results on Friday, November 7, 2025, prior to the market open....
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
25.08.2025
ANIP
LISTED
NASDAQ
ANI Pharmaceuticals to Present at Upcoming Investor Conferences
News Preview
PRINCETON, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, along with members of the Company’s executive leadership team will present at two upcoming investor conferences as follows:...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.08.2025
ANIP
LISTED
NASDAQ
ANI Pharmaceuticals Reports Record Second Quarter 2025 Financial Results and Raises 2025 Guidance
News Preview
BAUDETTE, Minn., Aug. 08, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced financial results and business highlights for the second quarter ended June 30, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
01.08.2025
ANIP
LISTED
NASDAQ
ANI Pharmaceuticals to Discuss Second Quarter 2025 Financial Results on August 8, 2025, at 8:30 a.m. ET
News Preview
PRINCETON, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its second quarter 2025 financial results on Friday, August 8, 2025, prior to the market open....
Themefolio
Profiler
Peergroup
© Globe Newswire
12.06.2025
ANIP
LISTED
NASDAQ
ANI Pharmaceuticals Announces Presentation of New Preclinical Data
News Preview
The Use of Purified Cortrophin® Gel in Murine Collagen-Induced Arthritis Mouse Model presented as a poster at the European Alliance of Associations for Rheumatology (EULAR) 2025 Congress The Use of Purified Cortrophin® Gel in Murine Collagen-Induced Arthritis Mouse Model presented as a poster at the European Alliance of Associations for Rheumatolog...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.05.2025
ANIP
LISTED
NASDAQ
ANI Pharmaceuticals to Participate at the H.C. Wainwright 3rd Annual BioConnect Conference at NASDAQ
News Preview
PRINCETON, N.J., May 12, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ as follows:...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.05.2025
ANIP
LISTED
NASDAQ
ANI Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Raises 2025 Guidance
News Preview
BAUDETTE, Minn., May 09, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced financial results and business highlights for the first quarter ended March 31, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
14.03.2025
ANIP
LISTED
NASDAQ
ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN® Label
News Preview
BAUDETTE, Minn., March 14, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded label for ILUVIEN (fluocinolone acetonide intravitreal implant) that includes an indication for the treatment of chronic non-infectious uveitis...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.02.2025
ANIP
LISTED
NASDAQ
ANI Pharmaceuticals Reports Record Fourth Quarter and Full-Year 2024 Financial Results and Raises 2025 Guidance
News Preview
BAUDETTE, Minn., Feb. 28, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced financial results and business highlights for the fourth quarter and full year ended December 31, 2024....
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
13.01.2025
ANIP
LISTED
NASDAQ
Alcami Announces CEO Transition
News Preview
Long time industry leader, Chairman of the Board Patrick Walsh replaces CEO Bill Humphries
DURHAM, N.C., Jan. 13, 2025 /PRNewswire/ -- Alcami Corporation ("Alcami"), a leading contract development and manufacturing organization (CDMO), today announced the resignation of Bill Humphries. Alcami's Board Chair and former Chief Executive Officer Patr...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.12.2024
ANIP
LISTED
NASDAQ
ANI Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
News Preview
PRINCETON, N.J., Dec. 30, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer; Stephen Carey, Chief Financial Officer; and Dr. Mary Pao, Chief Medical Officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesd...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.11.2024
ANIP
LISTED
NASDAQ
ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance
News Preview
BAUDETTE, Minn., Nov. 08, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced financial results and business highlights for the three months ended September 30, 2024....
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2024
ANIP
LISTED
NASDAQ
ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET
News Preview
PRINCETON, N.J., Oct. 30, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its third quarter 2024 financial results on Friday, November 8, 2024, prior to the market open....
Themefolio
Profiler
Peergroup
© Globe Newswire
25.10.2024
ANIP
LISTED
NASDAQ
ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.06%
News Preview
PRINCETON, N.J., Oct. 25, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that following final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA), the Company launched Estradiol Gel, 0.06%. ANI’s Estradiol Gel, 0.06% is the generic versio...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2024
ANIP
LISTED
NASDAQ
ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences
News Preview
PRINCETON, N.J., Sept. 16, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or “the Company”) (Nasdaq: ANIP) today announced the completion of its previously announced acquisition of Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”)....
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2024
ANIP
LISTED
NASDAQ
ANI Pharmaceuticals Initiates Closing of Acquisition of Alimera Sciences
News Preview
PRINCETON, N.J., Sept. 16, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (“ANI” or the “Company”) announced today that the Company has initiated closing logistics for the previously announced acquisition of Alimera Sciences, Inc. (Nasdaq: ALIM)....
Themefolio
Profiler
Peergroup
© Globe Newswire
13.09.2024
ANIP
LISTED
NASDAQ
ANI Pharmaceuticals Launches Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution
News Preview
PRINCETON, N.J., Sept. 13, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution, 6.25 mg/15 mg per 5 mL....
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2024
ANIP
LISTED
NASDAQ
ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger
News Preview
ANI and Alimera Scheduled the Closing for September 16, 2024 ANI and Alimera Scheduled the Closing for September 16, 2024...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2024
ANIP
LISTED
NASDAQ
ANI Pharmaceuticals Provides Update on Closing of Acquisition of Alimera Sciences
News Preview
PRINCETON, N.J., Sept. 10, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or “the Company”) (Nasdaq: ANIP) today provided an update on the status of the completion of its previously announced acquisition of Alimera Sciences, Inc. (“Alimera”) (Nasdaq: ALIM)....
Themefolio
Profiler
Peergroup
© Globe Newswire
13.08.2024
ANIP
LISTED
NASDAQ
ANI Pharmaceuticals, Inc. Closes $316.25 Million Convertible Senior Notes Offering Including Full Exercise of Initial Purchasers’ Option to Purchase Additional Notes
News Preview
PRINCETON, N.J., Aug. 13, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the closing of its offering of $316,250,000 aggregate principal amount of 2.25% convertible senior notes due 2029 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Sec...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.08.2024
ANIP
LISTED
NASDAQ
ANI Pharmaceuticals, Inc. Prices Upsized $275.0 Million Convertible Senior Notes Offering
News Preview
PRINCETON, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the pricing of its offering of $275,000,000 aggregate principal amount of 2.25% convertible senior notes due 2029 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Sec...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.08.2024
ANIP
LISTED
NASDAQ
ANI Pharmaceuticals, Inc. Announces Proposed Convertible Senior Notes Offering
News Preview
PRINCETON, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced its intention to offer, subject to market and other conditions, $250,000,000 aggregate principal amount of convertible senior notes due 2029 (the “notes”) in a private offering to persons reasonably believed to be quali...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.08.2024
ANIP
LISTED
NASDAQ
ANI Pharmaceuticals Reports Second Quarter 2024 Financial Results and Raises 2024 Guidance
News Preview
BAUDETTE, Minn., Aug. 06, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced financial results and business highlights for the three months ended June 30, 2024....
Themefolio
Profiler
Peergroup
© Globe Newswire
15.07.2024
ANIP
LISTED
NASDAQ
ANI Pharmaceuticals Announces the FDA Approval and Launch of L-Glutamine Oral Powder
News Preview
PRINCETON, N.J., July 15, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that following final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA), the Company launched L-Glutamine Oral Powder. ANI’s L-Glutamine Oral Powder is the generic...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.07.2024
ANIP
LISTED
NASDAQ
ANI Pharmaceuticals Announces the FDA Approval and Launch of Naproxen Delayed-Release Tablets, USP
News Preview
PRINCETON, N.J., July 02, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that it received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) and launched Naproxen Delayed-Release Tablets, USP. ANI’s Naproxen Delayed-Release Tablets is the generic...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.06.2024
ANIP
LISTED
NASDAQ
ANI Pharmaceuticals’ CEO Nikhil Lalwani Named EY Entrepreneur Of The Year® 2024 New Jersey Award Winner
News Preview
Recognized for outstanding entrepreneurial leadership, driving impressive growth, and patient impact Recognized for outstanding entrepreneurial leadership, driving impressive growth, and patient impact...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.06.2024
ANIP
LISTED
NASDAQ
ANI Pharmaceuticals to Further Expand Rare Disease Business through Acquisition of Alimera Sciences
News Preview
Conference call scheduled for today at 8:30 a.m. ET...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.05.2024
ANIP
LISTED
NASDAQ
ANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare Conference
News Preview
BAUDETTE, Minn., May 29, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will present at the 2024 Jefferies Global Healthcare Conference in New York City as follows:...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.05.2024
ANIP
LISTED
NASDAQ
ANI Pharmaceuticals Reports Record First Quarter 2024 Financial Results and Reiterates 2024 Guidance
News Preview
BAUDETTE, Minn., May 10, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced financial results and business highlights for the three months ended March 31, 2024....
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
